{"title":"在治疗慢性肝病时合理选择肝保护剂","authors":"S. N. Mekhtiev, O. A. Mekhtieva, O.M. Berko","doi":"10.33978/2307-3586-2023-19-35-50-58","DOIUrl":null,"url":null,"abstract":"The modern pharmacological industry provides healthcare professionals and patients with the widest choice of medicines (drugs) and biologically active additives. At the same time, the choice of the drug, in addition to the instructions for use and clinical recommendations, is influenced by personal experience of use (both the doctor and the patient), the cost of the drug, advertising and other factors. The Register of Medicines of Russia contains about 30 hepatoprotectors and their combinations, represented by more than 130 original drugs and their generics. This article presents data on the epidemiology of liver diseases in the world and in Russia, the general stages of the pathogenesis of liver lesions and the key points of application of drugs, as well as the role of a new hepatoprotector (a combination of ursodeoxycholic acid with glycyrrhizic acid) in the treatment of liver diseases","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rational Сhoice of Нepatoprotectors in the Treatment of Chronic Liver Diseases\",\"authors\":\"S. N. Mekhtiev, O. A. Mekhtieva, O.M. Berko\",\"doi\":\"10.33978/2307-3586-2023-19-35-50-58\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The modern pharmacological industry provides healthcare professionals and patients with the widest choice of medicines (drugs) and biologically active additives. At the same time, the choice of the drug, in addition to the instructions for use and clinical recommendations, is influenced by personal experience of use (both the doctor and the patient), the cost of the drug, advertising and other factors. The Register of Medicines of Russia contains about 30 hepatoprotectors and their combinations, represented by more than 130 original drugs and their generics. This article presents data on the epidemiology of liver diseases in the world and in Russia, the general stages of the pathogenesis of liver lesions and the key points of application of drugs, as well as the role of a new hepatoprotector (a combination of ursodeoxycholic acid with glycyrrhizic acid) in the treatment of liver diseases\",\"PeriodicalId\":11400,\"journal\":{\"name\":\"Effective Pharmacotherapy\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Effective Pharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33978/2307-3586-2023-19-35-50-58\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Effective Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33978/2307-3586-2023-19-35-50-58","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rational Сhoice of Нepatoprotectors in the Treatment of Chronic Liver Diseases
The modern pharmacological industry provides healthcare professionals and patients with the widest choice of medicines (drugs) and biologically active additives. At the same time, the choice of the drug, in addition to the instructions for use and clinical recommendations, is influenced by personal experience of use (both the doctor and the patient), the cost of the drug, advertising and other factors. The Register of Medicines of Russia contains about 30 hepatoprotectors and their combinations, represented by more than 130 original drugs and their generics. This article presents data on the epidemiology of liver diseases in the world and in Russia, the general stages of the pathogenesis of liver lesions and the key points of application of drugs, as well as the role of a new hepatoprotector (a combination of ursodeoxycholic acid with glycyrrhizic acid) in the treatment of liver diseases
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
